Summary:
- Researchers are exploring a new immune therapy approach to treating depression. This involves using the body's own immune system to target inflammation, which is believed to play a role in depression.
- The therapy uses a vaccine-like approach to stimulate the immune system to produce antibodies that can block a specific inflammatory protein called interferon-gamma. Reducing this protein may help alleviate depression symptoms.
- Early studies in animals and humans have shown promising results, with the potential to provide a new, more targeted treatment option for depression. Further research is needed to fully understand the long-term effects and effectiveness of this approach.